Cure Pharmaceutical navigates CBD acquisition, licensing dispute
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen adds executive VP; co-founder Myers to step down
Inogen, a Goleta-based medical technology company that makes portable oxygen concentrators, announced April 7 that it has hired Georg Parr as executive vice president and chief commercial officer. Byron Myers, a member of Inogen’s founding team and the current executive vice president for marketing, will step down on June 4, as will Arron Retterer, the Read More →
Inogen’s new CEO looks to the future
As life begins to regain a bit of the normalcy that existed before the COVID-19 pandemic, Goleta-based Inogen is ready to not only get back to its roots, but also lay the foundation for a new direction for the company. Inogen, a medical device company specializing in portable oxygen concentrators, hired a new CEO on Read More →
How to borrow $4 billion: With financing secure, path is nearly clear for Teledyne/Flir deal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Revenues and losses both grew at Cure in 2020
Cure Pharmaceutical, an Oxnard company with a CBD products subsidiary, reported steep revenue growth but rising net losses in the fourth quarter and full year of 2020. In an annual statement released April 1, Cure reported revenue of $2.1 million in the final quarter of 2020, up 229% from the same quarter a year before. Read More →
Amgen announces $721M acquisition
Amgen reported its second major acquisition of the month, as the Thousand Oaks-based firm announced March 30 that it will acquire Rodeo Therapeutics Corporation, a privately held biotech company based in Seattle. The deal is worth more than $700 million, $55 million of which will be paid upfront, with up to $666 million more in Read More →
QAD shares climb 7% after earnings report
QAD, a cloud software company for the manufacturing industry, saw accelerated growth from its subscription services in the final quarter of the fiscal year, providing a bit of a bounce back for the Santa Barbara company. QAD generated revenue worth $83 million in the final quarter of the fiscal year, which ended Jan. 31. That Read More →
